Asia Pacific Diabetic Foot Ulcer Treatment Market
No. of Pages: 184 | Report Code: TIPRE00024703 | Category: Life Sciences
No. of Pages: 184 | Report Code: TIPRE00024703 | Category: Life Sciences
APAC consists of five major countries namely China, India, Japan, South Korea, and Australia. The market is also evaluated for the Rest of APAC market. The region holds third-largest position for the diabetic foot ulcer treatment market at a global level. China is the fast-growing county in the Asia Pacific. The country still has many emerging and developing markets where patients don’t have access to basic wound care. Wound care and treatment in healthcare settings is expanding quickly and driven primarily by increasing awareness of the technique and its various applications. The increasing prevalence of diabetes has become a global public health concern worldwide. China ranks number one, with the highest number of people with diabetes. The prevalence of diabetes and diabetic complications increased alarmingly in the last few years. As per the WHO, almost 10% of all adults in China – about 110 million people – currently live with diabetes. The number is expected to increase to 150 million by 2040 – with major health, social and economic consequences. Environmental factors such as obesity, aging, diet, and physical activity; genetic factors; contributed in accelerating diabetes population. Rising research activities to introduce novel wound treatment products and burgeoning use of 3D printing in wound care management are the major factor driving the growth of the APAC diabetic foot ulcer treatment market.
In case of COVID-19, APAC is highly affected specially India. People are packing India's public hospitals, as many are unable to afford private ones that generally uphold higher standards of care. The outbreak has severely affected the tourism industry and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent disease transmission. All these factors will impact the Diabetic Foot Ulcer Treatment market for a short period of time. The focus on the wound care treatments is less as government and population in the region are more focused on the treatment of COVID 19. The dermatology clinics, hospitals, and surgical centers are open for only emergency services. China is specifically facing issues that this epidemic has caused, leading to disruption of the supply chain, projected decreases in revenue and sales within all industries. As the visits to healthcare settings has declined in response to the pandemic to the regions like South Korea and Japan which has negative impact on the wound care industry. In India, shutdown of the entire transportation within the country, and many provinces are establishing border restrictions within the country. This has led to paralyzed supply chains for any industry in India. However, essential medical product supply is not restricted but the production has been affected due to restriction on number of staff working in the companies. As the vaccination progress, the demand for wound care products is expected to increase which will support the diabetic foot ulcer treatment market.
Strategic insights for the Asia Pacific Diabetic Foot Ulcer Treatment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 976.51 Million |
| Market Size by 2028 | US$ 1,723.22 Million |
| Global CAGR (2021 - 2028) | 8.5% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | Asia-Pacific
|
| Market leaders and key company profiles |
The geographic scope of the Asia Pacific Diabetic Foot Ulcer Treatment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The APAC diabetic foot ulcer treatment market is expected to grow from US$ 976.51 million in 2021 to US$ 1,723.22 million by 2028; it is estimated to grow at a CAGR of 8.5% from 2021 to 2028. Escalating prevalence of diabetes and related chronic wounds is expected to surge the market growth. Depending on time taken to heal, wounds can be classified as acute and chronic. Diabetes has emerged as one of the most impactful health emergencies of the region in the 21st century. Diabetes affects many parts of the body, particularly the feet. Diabetic foot ulcers are sores developed on feet; they can also develop from seemingly trivial injuries to the feet. Diabetic foot ulcers are the common causes of amputation due to diabetes. According to a report published in the International Journal of Endocrinology in 2017, ~15–25% of patients with diabetes are susceptible to foot ulcers during their lifetime. The risk of developing diabetic foot ulcers in patients diagnosed with diabetes is anticipated to be ~2%; however, in patients with a previous history of foot ulceration, this risk is expected to increase to 17–60% over the next three years. ~20% of hospital admissions in people with diabetes are because of foot ulcers. As there are continuous occurrences of injuries caused due to diabetes in low- and medium-income, and high-income countries, the demand for diabetic foot ulcer treatments is on rise across APAC region.
In terms of type, the advanced wound care dressings segment accounted for the largest share of the APAC diabetic foot ulcer treatment market in 2020. In terms of ulcer type, the neuro-ischemic ulcers segment held a larger market share of the APAC diabetic foot ulcer treatment market in 2020. Further, the hospitals segment held a larger share of the APAC diabetic foot ulcer treatment market based on end user in 2020.
A few major primary and secondary sources referred to for preparing this report on the APAC diabetic foot ulcer treatment market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are 3M; B. Braun Melsungen AG; Cardinal Health Inc; Coloplast Group; ConvaTec Group Plc; Medline Industries, Inc.; MiMedx; Mölnlycke Health Care AB.; Organogenesis Inc.; Smith & Nephew; and URGO.
The Asia Pacific Diabetic Foot Ulcer Treatment Market is valued at US$ 976.51 Million in 2021, it is projected to reach US$ 1,723.22 Million by 2028.
As per our report Asia Pacific Diabetic Foot Ulcer Treatment Market, the market size is valued at US$ 976.51 Million in 2021, projecting it to reach US$ 1,723.22 Million by 2028. This translates to a CAGR of approximately 8.5% during the forecast period.
The Asia Pacific Diabetic Foot Ulcer Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Diabetic Foot Ulcer Treatment Market report:
The Asia Pacific Diabetic Foot Ulcer Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Diabetic Foot Ulcer Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Diabetic Foot Ulcer Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Diabetic Foot Ulcer Treatment Market
